NuScale Power Corporation specializes in the development and deployment of advanced nuclear reactor technology, focusing on its novel NuScale Power Module (NPM), a 77-megawatt scalable clean energy solution. Operating within the Industrials sector, specifically in Specialty Industrial Machinery, NuScale aims to provide a flexible and potentially safer alternative to traditional nuclear power.
Examining the most recent reported quarters, NuScale Power's performance shows a trend of revenue generation alongside significant EPS misses. In Q4 2025, the company reported revenue of $1.81 million against an EPS actual of -$0.80, missing the estimate of -$0.1325. This followed Q3 2025, where revenue was $8.24 million with an EPS actual of -$1.85, a substantial miss from the -$0.145 estimate. Prior to these, Q2 2025 saw revenue of $8.05 million and an EPS actual of -$0.13, missing the -$0.112 estimate, and Q1 2025 reported revenue of $13.38 million with an EPS actual of -$0.11, narrowly missing the -$0.115 estimate. The company has consistently reported actual EPS below estimates in the most recent reported quarters.
Historically, NuScale Power has faced challenges in meeting earnings expectations, with a pattern of significant EPS misses against analyst estimates across the reported periods. While revenue figures have been reported in recent quarters, the focus remains on the company's ability to achieve profitability. The trajectory indicates a consistent struggle to align actual earnings with projections, highlighting a key area for investor scrutiny.
Recent news surrounding NuScale Power indicates significant headwinds, including securities-fraud class action lawsuits alleging misrepresentations concerning its commercialization partner, ENTRA1 Energy. These legal challenges, coupled with analyst skepticism and insider share sales, have impacted investor sentiment and contributed to stock declines. Furthermore, commentary characterizing the company as a "science project" and reports of project delays, such as a reduced price target from UBS, underscore concerns about the commercialization strategy and timeline.
Looking ahead, investors will be watching for developments in the ongoing securities fraud lawsuits and any official responses from NuScale regarding project timelines and capital deployment. Key will be any updates provided during the upcoming Q1 2026 earnings conference call, scheduled for May 7, 2026, for insights into the company's operational and financial trajectory amidst these challenges.
